Are Eye Injections Safe for Your Heart and Your Stroke Risk?
Eye Injections and Your Heart at a Glance
If your eye doctor has recommended anti-VEGF injections and you worry about your heart or a past stroke, here is the reassuring version. For most people, the overall risk to the heart and brain from these injections is low. The main anti-VEGF drugs, Avastin, Lucentis, and Eylea, are all widely used, and numerous studies comparing them have found only minimal differences in the risks between the drugs1. This page explains where the concern comes from, what the numbers actually show, who should be most careful, and how to make the decision with your doctors. It does not replace advice about your own eyes and heart.
It helps to remember what these injections are for. Anti-VEGF injections treat wet macular degeneration, diabetic retinopathy, retinal vein occlusion, and swelling of the retina by blocking a protein called VEGF, which reduces leaking abnormal blood vessels, and they improve vision in about 1 of every 3 people and stabilize it in about 9 of every 102. These are among the few treatments that can hold on to sight that would otherwise be lost. So the real question is not 'injection or nothing,' but how to weigh a large, proven vision benefit against a small, uncertain heart risk.
Stroke and Heart Attack Warning Signs to Call 911 About
Whether or not it has anything to do with an eye injection, a stroke or heart attack is a call-911-now emergency, because fast treatment saves brain and heart tissue. Learn these signs and act on them the same minute they appear:
- Face drooping on one side, or a sudden crooked smile
- Arm or leg weakness or numbness, especially on one side
- Slurred speech or trouble understanding words
- Sudden severe headache, confusion, or loss of balance
- Chest pain or pressure, or pain spreading to the arm, jaw, or back
- Sudden shortness of breath, cold sweat, or nausea
Call 911 immediately, do not drive yourself, and note the time symptoms started. These events are rare after eye injections, and most happen for the usual reasons unrelated to treatment, but the correct response is the same either way: emergency care now gives the best chance of recovery.
Separate from the heart, a rare but serious eye problem can follow any injection. As with any injection into the eye, one uncommon risk is a serious infection inside the eye. Call your eye doctor the same day, or go to an emergency room if you cannot reach them, if the treated eye becomes increasingly painful, much redder, more light-sensitive, or your vision drops in the days after an injection. Caught early, these problems are far more treatable than if you wait.
What 'Safe for My Heart' Really Means
The concern is reasonable, because the same protein the drug blocks in your eye also helps blood vessels elsewhere in the body. When VEGF-blocking drugs are given as an infusion into a vein for cancer, in much larger doses, they can raise blood pressure and the risk of clots. The honest question is whether the tiny amount used in the eye does the same thing. The reassuring news is that the eye dose is a small fraction of a cancer dose, and very little reaches the bloodstream.
For most people, the level of worry should be low but not zero. The evidence, covered below, points to a small and uncertain risk rather than a clear danger. That picture changes a little if you already have a high baseline risk, such as a recent stroke or heart attack, which is exactly why this is a conversation to have with both your eye doctor and the doctor who manages your heart, rather than a decision to make alone or out of fear.
Why There Is a Question About the Heart and Stroke at All
VEGF, short for vascular endothelial growth factor, is a signal that tells blood vessels to grow and to become leaky. In a diseased retina that process damages sight, which is why blocking it helps the eye. The same signal, though, plays a housekeeping role in normal blood vessels throughout the body. Blocking it in large, body-wide doses is what raises the theoretical concern about clots that could cause a stroke or heart attack.
Some people start from a higher baseline. Older age, diabetes, high blood pressure, and a history of a stroke or heart attack all raise cardiovascular risk on their own, before any injection. If several of these apply to you, it is sensible to weigh the decision more carefully and to loop in your primary care doctor or cardiologist. This is not a reason to refuse sight-saving care; it is a reason to plan it thoughtfully and to keep your other conditions well controlled.
The single most reassuring fact is one of scale. The injection places a small dose directly where it is needed, inside the eye, rather than flooding the whole body through a vein. Only a small amount escapes into the bloodstream, and it clears over time. That is the main reason the body-wide clot risk seen with high-dose intravenous use has not translated into a clear, large risk from the eye injections.
What to Watch For After an Injection
Most of what you feel after an injection is expected and harmless. Mild soreness or a gritty feeling, a small red spot on the white of the eye, and a few new floaters are common and settle within a day or two. Knowing that these are normal is part of fear-calibration: it lets you tell an ordinary healing eye from the rare warning signs that genuinely need action, without treating every twinge as an emergency.
Two categories deserve prompt action. For the body, the stroke and heart attack signs listed earlier mean call 911. For the eye, worsening pain, increasing redness, growing light sensitivity, or a drop in vision over the days after an injection mean call your eye doctor the same day. Neither is common, and the great majority of injections cause no such problems, but both are worth knowing so you can act quickly if they ever appear.
How Big Is the Heart and Stroke Risk, Really?
Putting it in perspective helps. Numerous studies comparing the main anti-VEGF drugs have found only minimal differences in the risks between them1. In other words, no single drug stood out as clearly riskier for the heart. For context, some strokes and heart attacks are expected in any older group over two years whether or not they are treated, which is part of why studies have found it hard to show that these eye injections clearly add risk.
Taken together, the evidence is reassuring rather than alarming, though not a guarantee of zero risk. Studies have not shown a large, consistent jump in strokes or heart attacks from the eye injections, and where a signal appears it is small and mainly a short-term concern for people who already have high cardiovascular risk. Balanced against a treatment that protects sight for most people who receive it, the realistic outlook for a typical patient is that the vision benefit clearly outweighs the small heart and stroke risk.
People with existing heart or vascular disease understandably ask whether to pause treatment. Reassuringly, the evidence points the other way. In a large national study, giving anti-VEGF injections around the time of a stroke or heart attack was linked to lower short-term death rates and fewer complications, which supports continuing treatment rather than stopping or delaying it3. The safest path is usually a coordinated one, where your eye doctor and heart doctor agree on timing, not an abrupt stop that risks your vision.
Who to Talk To and When
The right team makes this easier. Tell your retina specialist about any heart disease, prior stroke, blood thinners, and your other doctors. If you have recently had a stroke or heart attack, ask whether the timing of your next injection should be discussed with your cardiologist. Keep your blood pressure, diabetes, and cholesterol well managed between visits, since those steps do more for your stroke risk than any decision about the eye injection itself.
Anti-VEGF injections are given and managed by a retina specialist, not at a routine eye exam, and questions about your heart belong with your primary care doctor or cardiologist. For sudden stroke or heart attack signs, the answer is 911, not a clinic call. For a worsening eye after an injection, call your eye doctor the same day. For planning and reassurance, a scheduled conversation with the specialists who know your history is the right setting.
Common Questions About Eye Injections and Heart Health
For most people it is very unlikely. The drug is given in a tiny dose inside the eye, and little reaches the bloodstream. In the large trials, serious events like stroke and heart attack happened at a low rate, close to what is expected in an older group over two years whether or not they were treated. The risk is not zero, and it deserves attention if you already have heart disease, but it is small for a typical patient.
The differences appear small. Studies comparing the main drugs have found only minor differences in their risks. If you have significant heart or stroke risk, your retina specialist can factor that into which drug and schedule to use, but there is no single option that is clearly the 'heart-safe' one for everyone. This is a reasonable thing to ask about directly at your consultation.
Do not stop on your own, because that can risk permanent vision loss. Bring it to your retina specialist and your cardiologist together. Reassuringly, research suggests that continuing injections around the time of a cardiovascular event is linked to better short-term survival, not worse. Your doctors may simply coordinate timing. The goal is a shared plan that protects both your sight and your heart, rather than an abrupt decision made out of worry.
Only to a small degree. VEGF does help blood vessels throughout the body, which is the theoretical basis for the concern. But the eye dose is a small fraction of the doses used intravenously for other diseases, and only a little enters the bloodstream before clearing. That is the main reason the body-wide risks seen with high-dose intravenous use have not clearly carried over to the small doses used for the eye.
Trust the serious signs. If you have chest pain, one-sided weakness, face drooping, slurred speech, or sudden severe headache, call 911, because those are emergencies regardless of the injection. If instead the treated eye becomes increasingly painful, red, or your vision drops over the next few days, call your eye doctor the same day. Ordinary mild soreness, a small red spot, or a few floaters are expected and usually settle on their own.
Usually yes, but confirm with the doctor who prescribed it. Anti-VEGF injections are generally given without stopping blood thinners, since the injection is very small, and stopping a blood thinner can carry its own risks. Never start or stop a heart or blood-thinning medicine on your own around an injection. Your retina specialist and prescribing doctor can tell you exactly what to continue, so you are not guessing between appointments.
More Questions, Plus What to Ask Your Doctor
Labels are required to note any potential risk seen in studies, even a small or uncertain one, so doctors and patients can make informed choices. The label's mention of a potential clot-related risk reflects honesty about what has been observed, not proof that the injection caused those events. Reading it as a warning to weigh, rather than a reason to refuse sight-saving care, is the balanced way to use that information.
Diabetes raises cardiovascular risk on its own, so people with diabetic eye disease often start from a higher baseline. That is a reason to keep blood sugar, blood pressure, and cholesterol well controlled and to involve your primary care doctor, not a reason to avoid treatment that protects your sight. In trials that included people with diabetes, the injections remained a standard, worthwhile treatment. Your care team can tailor the plan to your overall health.
Focus on the things with the biggest payoff. Controlling blood pressure, managing diabetes and cholesterol, not smoking, staying active, and taking any prescribed heart medicines do far more for your stroke and heart risk than any choice about the eye injection. Keeping these in good shape also means that if a rare event ever happens, you are in a stronger position. Your primary care doctor can help you set concrete targets.
- Given my heart history, how do you weigh the vision benefit against the small clot risk for me?
- Should the timing of my injections be coordinated with my cardiologist or primary care doctor?
- Is one anti-VEGF drug or schedule preferable for my particular heart or stroke risk?
- Should I continue my blood thinner or aspirin as usual around each injection?
- Which symptoms after an injection should make me call you, and which mean call 911?
- American Academy of Ophthalmology (EyeSmart) (2024). What's the Difference Between Avastin, Eylea and Lucentis?.
- American Academy of Ophthalmology (EyeSmart) (2024). Anti-VEGF Treatments.
- American Academy of Ophthalmology (Editors' Choice) (2025). Intravitreal Anti-VEGF Injections Appear to Be Safe Around Cardiovascular Events.